Morepen Laboratories Ltd announces successful completion of USFDA inspection of API facility at Baddi

The United States Food and Drug Administration ('USFDA') conducted an inspection of the API manufacturing facility, at Baddi, Himachal Pradesh, of Morepen Laboratories Limited.

The facility has been cleared by USFDA on 24th March 2023 without any adverse observation (NIL 483).

Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 24.43 as compared to the previous close of Rs. 25.62. The total number of shares traded during the day was 438584 in over 2327 trades.

The stock hit an intraday high of Rs. 25.88 and intraday low of 24.07. The net turnover during the day was Rs. 10927042.00.

Source : Equity Bulls

Keywords

MorepenLaboratories INE083A01026 APIManufacturingFacility Baddi HimachalPradesh USFDA NoObservation